Long-term complete remission of metastatic combined hepatocellular-cholangiocarcinoma with nivolumab following failure of targeted therapies: a case report
Frontiers in Oncology · 14.04.2026 · 16
DOI: 10.3389/fonc.2026.1515511 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 14.04.2026. Verfasst von Young Mi Hong. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare and aggressive primary liver malignancy with limited treatment options and poor prognosis. We report the case of 33-year-old male with chronic hepatitis B who underwent hepatectomy and pulmonary metastasectomy for HCC with lung metastases. Histological examination revealed cHCC-CCA. However, new lung and chest wall metastases emerged and sorafenib and regorafenib was administered and failed to control tumor progression. The patient was then treated with nivolumab, which led to a complete remission (CR) after 37 weeks. Remarkably, this response has been sustained for over six years without any immune-related adverse events. This case represents a rare case of long-term CR in metastatic cHCC-CCA following treatment with nivolumab after failure of tyrosine kinase inhibitors, suggesting that nivolumab may represent a promising therapeutic option for this challenging malignancy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea.
- Liver Center, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
Zitieren
APA
Hong, Y. M. (2026). Long-term complete remission of metastatic combined hepatocellular-cholangiocarcinoma with nivolumab following failure of targeted therapies: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1515511
Vancouver
Hong YM. Long-term complete remission of metastatic combined hepatocellular-cholangiocarcinoma with nivolumab following failure of targeted therapies: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1515511
BibTeX
@article{Hong2026,
author = {Hong, Young Mi},
title = {Long-term complete remission of metastatic combined hepatocellular-cholangiocarcinoma with nivolumab following failure of targeted therapies: a case report},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1515511}
}
EUVIMED